Total and regional lung deposition of terbutaline sulphate inhaled via a pressurised MDI or via Turbuhaler®

70Citations
Citations of this article
4Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The deposition patterns of terbutaline sulphate delivered from pressurized metered dose inhaler (MDI) and Turbuhaler®have been compared by gamma scintigraphy. The radionuclide99mTc was used to label the formulations, and 1 mg terbutaline sulphate was subsequently inhaled from each device in a randomized cross-over fashion by eight healthy volunteers. Both devices were operated at their respective optimal inhalation flow rates. From the pressurised MDI, a mean 16.7% of the dose was deposited in the lungs (range 6.1-30.0%), compared to a mean 21.4% (range 14.1-30.8%) from Turbuhaler®. If the Turbuhaler®data were corrected for an observed mismatch in the size distributions of radiolabel and unlabelled drug, then the mean lung deposition from Turbuhaler®would be 29.3% of the dose. The distribution of radiolabel within the lungs was similar for each device, but oropharyngeal deposition was significantly reduced for Turbuhaler®(P < 0.01). It is concluded that pressurized MDI and Turbuhaler®produce broadly similar regional deposition in the lungs, but that the inter-subject variability of deposition is less for Turbuhaler®. © 1993.

Cite

CITATION STYLE

APA

Borgström, L., & Newman, S. (1993). Total and regional lung deposition of terbutaline sulphate inhaled via a pressurised MDI or via Turbuhaler®. International Journal of Pharmaceutics, 97(1–3), 47–53. https://doi.org/10.1016/0378-5173(93)90125-Y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free